OBJECTIVE: The aims of this study were to investigate whether general practitioners (GPs) who complied with quality prescribing indicators included in the pay-for-performance programmes also complied with quality prescribing indicators which are not linked to incentives and to compare the prescribing behaviour between those GPs who showed compliance with quality prescribing indicators linked to financial incentives and those who did not. DESIGN AND METHODOLOGY: This was a descriptive cross-sectional study which was conducted in 2007 in the Aljarafe Primary Care Area (Andalusia, Spain) and involved 37 Health Care Centres and 176 GPs. The main outcome was the results of a comparison of six quality prescribing indicators linked to incentives and 14 quality prescribing indicators not linked to incentives. The chi-square test was used to compare qualitative variables. Quantitative variables were tested using Student's t test upon confirmation of normality. RESULTS: Those GPs showing compliance with the indicators included in the pay-for performance programme showed low levels of compliance with quality prescribing indicators that were unincentivised. With respect to compliance with the indicators not linked to financial incentives, we found no statistical difference between GPs who showed compliance with incentivised indicators (n = 57) and those showing non-compliance (n = 112) in terms of drug selection, with the exception of the selection of second- and third-line antibiotics and antihistamines, nor in terms of the appropriate use of drugs linked to patient's clinical conditions. CONCLUSIONS: The compliance of GPs showing compliance with quality prescribing indicators included in pay-for-performance programmes was not better than that of those who showed no compliance with other relevant quality prescribing indicators not linked to financial incentives.
OBJECTIVE: The aims of this study were to investigate whether general practitioners (GPs) who complied with quality prescribing indicators included in the pay-for-performance programmes also complied with quality prescribing indicators which are not linked to incentives and to compare the prescribing behaviour between those GPs who showed compliance with quality prescribing indicators linked to financial incentives and those who did not. DESIGN AND METHODOLOGY: This was a descriptive cross-sectional study which was conducted in 2007 in the Aljarafe Primary Care Area (Andalusia, Spain) and involved 37 Health Care Centres and 176 GPs. The main outcome was the results of a comparison of six quality prescribing indicators linked to incentives and 14 quality prescribing indicators not linked to incentives. The chi-square test was used to compare qualitative variables. Quantitative variables were tested using Student's t test upon confirmation of normality. RESULTS: Those GPs showing compliance with the indicators included in the pay-for performance programme showed low levels of compliance with quality prescribing indicators that were unincentivised. With respect to compliance with the indicators not linked to financial incentives, we found no statistical difference between GPs who showed compliance with incentivised indicators (n = 57) and those showing non-compliance (n = 112) in terms of drug selection, with the exception of the selection of second- and third-line antibiotics and antihistamines, nor in terms of the appropriate use of drugs linked to patient's clinical conditions. CONCLUSIONS: The compliance of GPs showing compliance with quality prescribing indicators included in pay-for-performance programmes was not better than that of those who showed no compliance with other relevant quality prescribing indicators not linked to financial incentives.
Authors: Thomas F Gavagan; Hongyan Du; Barry G Saver; Gerald J Adams; Douglas M Graham; Regina McCray; G Ken Goodrick Journal: J Am Board Fam Med Date: 2010 Sep-Oct Impact factor: 2.657
Authors: Catherine Sermet; Veronique Andrieu; Brian Godman; Eric Van Ganse; Alan Haycox; Jean-Pierre Reynier Journal: Appl Health Econ Health Policy Date: 2010 Impact factor: 2.561
Authors: Anthony Scott; Peter Sivey; Driss Ait Ouakrim; Lisa Willenberg; Lucio Naccarella; John Furler; Doris Young Journal: Cochrane Database Syst Rev Date: 2011-09-07
Authors: Brian Serumaga; Dennis Ross-Degnan; Anthony J Avery; Rachel A Elliott; Sumit R Majumdar; Fang Zhang; Stephen B Soumerai Journal: BMJ Date: 2011-01-25
Authors: Tim Doran; Evangelos Kontopantelis; Jose M Valderas; Stephen Campbell; Martin Roland; Chris Salisbury; David Reeves Journal: BMJ Date: 2011-06-28
Authors: Nav Persaud; Taehoon Lee; Haroon Ahmad; Winny Li; Michael Sergio Taglione; Yathavan Rajakulasingam; Norman Umali; Andrew Boozary; Richard H Glazier; Tara Gomes; Stephen W Hwang; Peter Jüni; Michael Law; Muhammad M Mamdani; Braden Manns; Danielle Martin; Steve Morgan; Paul Oh; Andrew David Pinto; Baiju R Shah; Frank M Sullivan; Kevin E Thorpe; Karen Tu; Andreas Laupacis Journal: BMJ Open Date: 2017-06-12 Impact factor: 2.692